Pharma Journalist -

Alkermes plc announced that the U.S. Food and Drug Administration (FDA) has approved LYBALVI (olanzapine and samidorphan) for the treatment of adults with schizophrenia and for the…
Read More...

NRx Pharmaceuticals announced it has filed an application with U.S. Food and Drug Administration (FDA) requesting Emergency Use Authorization (EUA) for ZYESAMI (Aviptadil-acetate), to…
Read More...

Amgen and Kyowa Kirin Co., Ltd. announced an agreement to jointly develop and commercialize KHK4083, which is Kyowa Kirin's potential first-in-class, Phase 3-ready anti-OX40 fully human…
Read More...

ADVANZ PHARMA Corp. Limited a specialty pharmaceutical company with a strategic focus on complex medicines in Europe, announced the completion of its acquisition by a subsidiary of…
Read More...

SMi Group reports: The ‘Target Discovery for RNA Therapeutics’ workshop will be taking place on Tuesday 15th September 2021 in London, UK. SMi Group are delighted to announce that…
Read More...

Nexturn Bio Inc., a subsidiary of Nexturn Bioscience Co., Ltd., announced on May 26th that it had acquired a 50% stake in RosVivo Therapeutics Inc. ("Rosvivo"), an American new drug…
Read More...

AnHeart Therapeutics Co., Ltd. a clinical stage oncology company focused on underserved patients in global markets, and Innovent Biologics, Inc. an innovative leading biopharmaceutical…
Read More...

SMi Reports: Registration is now open for the 2nd Annual Next Generation Pharmaceutical Cleanroom Conference will convene in London on 6th and 7th October 2021 Following on from the…
Read More...

Samsung Biologics announced its plans to add mRNA vaccine drug substance (DS) manufacturing capability to the current facility in Songdo, ready for cGMP operations within the earlier…
Read More...

SMi Group Reports: Key updates released ahead of SMi’s 4th Annual Pharmaceutical Microbiology West Coast Conference, convening in just three weeks. SMi Group are delighted to…
Read More...